Eupraxia Pharmaceuticals Inc. (EPRX.TO)
CAD 4.59
(-2.34%)
CAD 4.59
(-2.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -27.91 Million | -18.77 Million | -14.64 Million | -403.92 Thousand | -5.17 Million | -8.32 Million |
| Net Income | -38.08 Million | -23.91 Million | -23.36 Million | -4.01 Million | -7.24 Million | -14.83 Million |
| Depreciation & Amortization | 209.91 Thousand | 193.27 Thousand | 111.52 Thousand | 116.8 Thousand | 201.93 Thousand | 125.82 Thousand |
| Deferred income taxes | -1.97 Million | -305.15 Thousand | 1.2 Million | 10.91 Thousand | -28.86 Thousand | 291.05 Thousand |
| Stock-based compensation | 1.41 Million | 1.43 Million | 4.21 Million | 228.68 Thousand | 544.95 Thousand | 2.91 Million |
| Change in working capital | 7.22 Million | 2.07 Million | -211.43 Thousand | 1.56 Million | 482.13 Thousand | 1.09 Million |
| Other non-cash items | 3.29 Million | 1.15 Million | 3.4 Million | 1.69 Million | 869.4 Thousand | 2.08 Million |
| Investing Cash Flow | -99.03 Thousand | 8.7 Million | -14.44 Million | 24.61 Thousand | -1.89 Million | -141.85 Thousand |
| Investments in PPE | -99.03 Thousand | -308.37 Thousand | -431.67 Thousand | - | -9479.00 | -141.85 Thousand |
| Acquisitions | - | 310.00 | - | 81.3 Thousand | - | - |
| Investment purchases | - | -310.00 | -9 Million | - | - | - |
| Sales/Maturities of investments | - | 9 Million | - | - | - | - |
| Other Investing Activities | - | 310.00 | -5.01 Million | -56.68 Thousand | -1.88 Million | - |
| Financing Cash Flow | 28.36 Million | 13.52 Million | 49.91 Million | -626.64 Thousand | 7.39 Million | 5.29 Million |
| Debt repayment | -107.22 Thousand | -185.18 Thousand | -586.42 Thousand | -1.1 Million | -116.86 Thousand | -7343.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 28.55 Million | 13.29 Million | 37.83 Million | - | - | 1.65 Million |
| Other Financing Activities | 28.03 Million | 410 Thousand | 12.66 Million | 474.05 Thousand | 7.51 Million | 5.3 Million |
| Accounts receivables | -139.97 Thousand | 310.06 Thousand | 190.88 Thousand | 727.68 Thousand | 135.27 Thousand | -208.57 Thousand |
| Accounts payables | 577.9 Thousand | 1.32 Million | - | - | - | - |
| Inventory | -577.9 Thousand | -1.32 Million | - | - | - | - |
| Other working capital | 7.36 Million | 1.76 Million | -402.31 Thousand | 832.36 Thousand | 346.86 Thousand | 1.3 Million |
| Cash at beginning of period | 24.73 Million | 20.89 Million | 150.12 Thousand | 1.15 Million | 823.48 Thousand | 3.99 Million |
| Cash at end of period | 25.5 Million | 24.73 Million | 20.89 Million | 150.12 Thousand | 1.15 Million | 823.48 Thousand |
| Capital Expenditure | -99.03 Thousand | -308.37 Thousand | -431.67 Thousand | - | -9479.00 | -141.85 Thousand |
| Effect of forex changes on cash | 821.39 Thousand | 396.83 Thousand | -81.62 Thousand | -143.00 | - | - |
| Net cash flow / Change in cash | 768.1 Thousand | 3.84 Million | 20.74 Million | -1 Million | 332.59 Thousand | -3.16 Million |
| Free Cash Flow | -28.01 Million | -19.08 Million | -15.07 Million | -403.92 Thousand | -5.18 Million | -8.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.21 Million | -8.14 Million | -4.35 Million | -38.08 Million | -11.57 Million | -7.82 Million |
| Depreciation & Amortization | 57.5 Thousand | 50.46 Thousand | 7818.00 | 209.91 Thousand | 49.9 Thousand | 49.18 Thousand |
| Deferred income taxes | - | - | -1.96 Million | -1.97 Million | 2.73 Million | -50.04 Thousand |
| Stock-based compensation | 1.47 Million | 213.13 Thousand | -72.3 Thousand | 1.41 Million | 481.91 Thousand | 685.23 Thousand |
| Change in working capital | -3.86 Million | 337.3 Thousand | 5.56 Million | 7.22 Million | 391.62 Thousand | 1.29 Million |
| Other non-cash items | 1.58 Million | -414.44 Thousand | -64.72 Thousand | 3.29 Million | -37.48 Thousand | 842.85 Thousand |
| Investing Cash Flow | 23.92 Thousand | -9155.61 | -41.17 Thousand | -99.03 Thousand | -12.75 Thousand | -8553.00 |
| Investments in PPE | -14.8 Thousand | -9155.61 | -41.17 Thousand | -99.03 Thousand | -12.75 Thousand | -8553.00 |
| Acquisitions | 38.73 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 28.51 Thousand | - | - | - | - | - |
| Financing Cash Flow | -5.88 Million | 31.22 Million | -7.29 Million | 28.36 Million | 22.03 Million | 6.01 Million |
| Debt repayment | -6.13 Million | -27.7 Thousand | -900.00 | -107.22 Thousand | -48.73 Thousand | -26.45 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -512.35 | - | - | - |
| Common Stock Issuance | 231.68 Thousand | 31.27 Million | -5.64 Million | 28.55 Million | 21.52 Million | 6.06 Million |
| Other Financing Activities | 21.94 Thousand | 31.41 Thousand | -46.75 | 28.03 Million | 555 Thousand | 6011.85 |
| Accounts receivables | 18.74 Thousand | 23.19 Thousand | -165.24 | -139.97 Thousand | -23.81 Thousand | 48.89 Thousand |
| Accounts payables | - | - | - | 577.9 Thousand | - | - |
| Inventory | - | - | - | -577.9 Thousand | - | - |
| Other working capital | -1.2 Million | 314.1 Thousand | 6615.34 | 7.36 Million | 415.44 Thousand | 1.24 Million |
| Cash at beginning of period | 48.59 Million | 33.2 Million | 33.2 Million | 24.73 Million | 19.09 Million | 18.84 Million |
| Cash at end of period | 31.9 Million | 48.59 Million | 19.34 Million | 25.5 Million | 33.2 Million | 19.09 Million |
| Capital Expenditure | -14.8 Thousand | -9155.61 | -41.17 Thousand | -99.03 Thousand | -12.75 Thousand | -8553.00 |
| Effect of forex changes on cash | -397.62 Thousand | -460.75 Thousand | 818.14 Thousand | 821.39 Thousand | 38.56 Thousand | -80.38 Thousand |
| Net cash flow / Change in cash | -16.68 Million | 15.38 Million | -13.86 Million | 768.1 Thousand | 14.11 Million | 247.38 Thousand |
| Free Cash Flow | -10.55 Million | -8.26 Million | -919.82 Thousand | -28.01 Million | -7.96 Million | -5.7 Million |
300800
PYT
STAL
ROVI
TWO-PA
HEAD